Strategic partnerships ASCO actively collaborates with leading cancer and liver societies and foundations (e.g., EASL, AASLD, ILCA, Conquer Cancer) which signals openness to joint initiatives, sponsorships, and co-funded research programs that SDRs can align with for sponsor-led trials, education campaigns, and events.

Tech-enabled reach ASCO leverages modern platforms and integrations (Google Gemini access for members, DoxGPT for guidelines, Apache Kafka data workflows, ShareFile) presenting opportunities to offer enhanced data services, AI-assisted decision tools, and sponsored content delivery within ASCO’s digital ecosystem.

Funding and grants With Conquer Cancer Foundation and substantial revenue scale, ASCO remains a major funder of oncology research and education, creating openings for grant sponsorships, endowed chair/young investigator awards, and programmatic sponsorships that align with corporate social responsibility goals.

Industry engagement Active participation in major oncology events (Gastrointestinal Cancers Symposium, HEOR and hematology meetings, ASH annual meeting presence) suggests strong opportunities for exhibit sponsorships, tailored content partnerships, and collaboration on symposia or virtual education modules.

Growth trajectory Large professional network (50,000+ oncology professionals) and mid-to-high seven-figure to eight-figure annual revenue indicate a sizeable, quality audience for premium memberships, credentialing services, data licensing, and targeted advertising aligned with cancer care practice and policy trends.